Erudio Bio, Inc.

posted: 04-Jan-2026 & updated: 04-Jan-2026

Report prepared by Sunghee Yun
Initial draft on 04-Jan-2026
Final Revised on 04-Jan-2026

Trip Overview

Korea • September 14-27, 2025 • Sunghee Yun

Landmark 13-night trip featuring breakthrough VC engagement and Silicon Valley network expansion. During this trip, Sunghee

  • secured Path Way Investment commitment for Series A
  • obtained StartX program endorsement from Andrew Radin (AI Head @ StartX)
  • worked on ₩500M angel investment from Jinsul Joo
  • delivered highly successful AI seminars at POSTECH, Korea University Business School, and SNU EE
  • participated in 3-day G-Quantum Bio Forum with critical networking outcomes
  • gained comprehensive regulatory and legal insights for medical device approval
  • expanded Korean medicine (한의학) collaboration network

Basic Logistics

Dates - September 14-27, 2025 (13 nights)

Flights

  • Outbound - OZ 211, SFO → ICN (departed Sep 14 @ 11:30pm PDT, arrived Sep 16 @ 4:30am KST)
  • Return - OZ 212, ICN → SFO (departed Sep 27 @ 8:55pm KST, arrived Sep 27 @ 3:30pm PDT)

Base - Suji, Gyeonggi-do

Regional Trips

  • Sep 17 - Day trip to Pohang
    • KTX-산천 4031: Gwangmyeong Station → Pohang Station (8:54am → 10:55am)
    • KTX-산천 254: Pohang Station → Gwangmyeong Station (9:36pm → 11:48pm)
  • Sep 22-24 - 2-night stay in Suwon for G-Quantum Bio Forum
    • Base: Courtyard Marriott Suwon

ACTION ITEMS

Owner Deliverable Deadline Status
Sunghee Yun Submit StartX program application with Andrew Radin’s endorsement Q4-2025 In Progress
Sunghee Yun / Kee-hyun Paik Execute USD 140k angel investment - terms finalized Oct-2025 COMPLETED
Sunghee Yun / Jin Young Heo Investigate MFDS biochip medical equipment approval process - specific procedures and documentation requirements Oct-2025 In Progress
Sunghee Yun / Ghayoung Lee Submit first draft IRB proposal to SNUBH - initiate iterative process (per 송재진’s advice) Oct-2025 In Progress
Jin Young Heo / Sunghee Yun Prepare press materials for 조시영 (Asia Economy) - execute frequent media exposure strategy Ongoing In Progress
Sunghee Yun Follow up with Path Way Investment on Series A timeline and requirements Q2-2026 In Progress
Sunghee Yun Coordinate with SNU EE faculty (홍용택, 김영민) on K-PAI and Erudio Bio collaboration Q4-2025 Pending
Sunghee Yun Follow up with Prof. 한수희 (POSTECH) on robotics/AI collaboration potential Q4-2025 Pending
Sunghee Yun Meet 김소연 (Money Today) in Silicon Valley as discussed Q4-2025 COMPLETED
Sunghee Yun / Jin Young Heo Develop customer story narratives based on Sep 20 meeting with 황혜련 Oct-2025 In Progress
Jin Young Heo / Sunghee Yun Apply regulatory/legal insights from G-Quantum Bio seminar to MFDS approval strategy Ongoing In Progress
Sunghee Yun Explore Pion Corporation technical partnership with 전찬석 Q4-2025 Pending
Sunghee Yun Continue Korean Medicine AI TF advisory role and explore collaboration models Ongoing Active

MILESTONES & TIMELINE

Immediate (Sep-Oct 2025):

  • ✅ Andrew Radin StartX endorsement obtained
  • ✅ Path Way Investment Series A commitment secured
  • ✅ USD 140k angel investment terms finalized
  • ✅ ₩500M angel investment secured for Korea entity
  • ✅ Comprehensive MFDS/KFDA regulatory pathway understanding achieved
  • ✅ Biochip medical equipment categorization confirmed
  • 🔄 StartX application submission
  • 🔄 SNUBH IRB first draft submission (iterative process initiated)
  • 🔄 MFDS approval process investigation

Short-term (Q4 2025):

  • StartX program application and acceptance
  • Angel investments execution (USD 140k + ₩500M)
  • MFDS biochip medical equipment regulatory pathway defined
  • SNUBH IRB approval progress (iterative submissions)
  • Press materials prepared and distributed
  • Korean Medicine AI collaboration model developed

Medium-term (2026):

  • Series A fundraising round with Path Way Investment participation
  • MFDS approval process initiated for VSA platform
  • K-PAI and academic collaborations formalized (SNU, POSTECH, KUBS)
  • Korean Medicine AI integration pilot projects
  • Silicon Valley-Korea network expansion leveraged

STRATEGIC INSIGHTS

  1. Silicon Valley Validation - StartX Endorsement:
    • Andrew Radin’s personal endorsement represents top-tier Silicon Valley validation
    • StartX acceptance would provide premier accelerator credentials
    • Opens doors to Stanford ecosystem and Silicon Valley investor network
    • Demonstrates Erudio Bio’s standing among elite Silicon Valley AI/biotech companies
  2. Venture Capital Market Validation:
    • Path Way Investment’s Series A commitment validates market appetite
    • 110-minute meeting duration (vs. 60-minute schedule) indicates genuine investor interest
    • Executive Director 문초혜’s audacious business model proposal (preclinical + clinical stage expansion) significantly enlarges TAM
    • Korean VC market receptivity extremely positive
  3. Academic Network as Strategic Asset:
    • SNU EE seminar’s exceptional success (long post-event networking line) demonstrates strong academic community engagement
    • Multiple top-tier universities engaged (SNU, POSTECH, KUBS, KAIST connections)
    • Academic partnerships provide:
      • Research collaboration potential
      • Talent pipeline access
      • Credibility and validation
      • K-PAI platform expansion opportunities
  4. Regulatory Pathway Clarity:
    • Biochip medical equipment categorization is critical for proper MFDS approval pathway
    • G-Quantum Bio Forum regulatory/legal seminar provided comprehensive framework
    • 20-year industry veteran (이홍국, Asia Medical) insights invaluable for market navigation
    • IRB iterative process understanding (송재진 advice) prevents perfectionism paralysis
  5. Media Strategy Paying Dividends:
    • 김소연 interview investment yielded two major articles including Gates Foundation feature
    • Press strategy validated: frequent exposure approach confirmed as optimal
    • Media coverage reinforces investor confidence and market credibility
  6. Korean Medicine - Untapped Market:
    • 한의학 exists uniquely in South Korea - represents differentiated market opportunity
    • AI TF advisory role provides inside track to this specialized market
    • Potential for first-mover advantage in Korean Medicine AI integration
  7. Network Effects Compounding:
    • Middle school friend (성태웅) connection led to critical medical equipment insights
    • Gauss Labs alumni network (이병찬, 조연희) providing ongoing value
    • James Rhee humanities connection expands interdisciplinary perspective
    • Each networking investment generating future returns
  8. Dual Entity Strategy Working:
    • ₩500M angel investment in Korea entity enables aggressive local execution
    • USD 140k US entity investment maintains Silicon Valley momentum
    • Path Way Series A commitment for US entity positions for scale
    • Korea entity as Asia market entry point validated
  9. G-Quantum Bio Forum - Major Strategic Event:
    • 3-day immersion provided:
      • Andrew Radin StartX connection (breakthrough outcome)
      • Silicon Valley-Korea network bridging (이시연, 임성원, 박군호)
      • Regulatory/legal comprehensive education
      • Government relations (김성진, Suwon City)
      • Bio/medical industry landscape visibility
    • Demonstrates value of premier industry events for network acceleration
  10. Time Investment in Relationship Building:
    • Multiple dinners, coffee chats, and networking sessions paying long-term dividends
    • Semiconductor industry insights from 채관엽 (multiple meetings) building deep understanding
    • Patient capital approach to network building validated

KEY MEETINGS & OUTCOMES

16-Sep-2025 - Strategic Planning & Business Development

7pm-8:30pm - Evening - Business Development Networking Dinner

Attendee

  • Sunghee Yun
  • 이상엽 (Vice Chairman, Korea SME Association - Korea Strong Small and Medium Enterprises Association (한국강소기업협회))

Outcomes

  • Established potential network contact for Erudio Bio business development
  • Identified influential connection throughout Korea Strong Small and Medium Enterprises Association)
  • He has his own startup with novel ideas - potential synergies

9pm-11pm - After Dinner - Strategic Meeting with Jin Young Heo

Attendees

  • Sunghee Yun
  • Jin Young Heo (CLO, Erudio Bio Korea)

Discussion Topics

  • General Erudio Bio strategies (SNUBH, Jeonbuk progress review)
  • G-Quantum Bio Conference planning (Sep 22-24 @ Suwon Convention Center)
    • Jin Young to attend Day 2 (Sep 23)
    • Sunghee to invite Jin Young to K-BioX Mentoring Sessions, G-BIVA Innovation Salon, Conference Dinner

17-Sep-2025 - POSTECH AI Seminar & Robotics Collaboration

12:30pm-2pm - AI Seminar for POSTECH students

Location

Pohang University of Science and Technology (POSTECH)

Title

“The AI Landscape Decoded - Where We Are, Where We’re Going” abstract

Invited by 한수희 교수 (Associate Professor, Creative IT Engineering / Electrical Engineering; Director, Unmanned Vehicle Research Institute, POSTECH)

5pm-6:45pm - Networking Dinner

Attendee

  • Sunghee Yun
  • 한수희 교수 (Associate Professor, Creative IT Engineering / Electrical Engineering; Director, Unmanned Vehicle Research Institute, POSTECH)

Outcomes

  • Gained deep insights into:
    • Robotics technology trends
    • Edge computing applications
    • AI technology developments in robotics field
  • Proposed potential collaboration with Erudio Bio
  • Fruitful conversation providing valuable AI/robotics trend insights

18-Sep-2025 - Dual AI Seminars: Major Academic Engagement

10:30am-12pm - Morning - Korea University Business School (KUBS)

AI Seminar for KUBS Studetns

Title

“The AI Revolution - How Smart Systems Are Reshaping Industries and Executive Decision-Making” abstract

Invited by 김기훈 교수 (Graduate School of Business, Korea University)

12pm-2pm - Lunch Meeting with 김기훈 교수

Discussion

Potential collaboration with Erudio Bio & K-PAI

Outcome

Established relationship with KUBS for potential partnerships

4:30pm-6:30pm - Afternoon & Evening - SNU EE 4과세미나

Title

“AI Pulse Check - What Silicon Valley Is Actually Building Right Now” abstract

Invited by 홍용택 교수 (Professor & Department Chair, Electrical and Computer Engineering, Seoul National University)

Pre-Seminar Activity

15-minute tea time with 홍용택 교수

CRITICAL OUTCOMES - EXTREMELY SUCCESSFUL EVENT

  • Exceptional audience engagement:
    • Strong eye contact and active participation throughout
    • Numerous insightful questions during seminar
  • Long line of attendees post-seminar wanting to:
    • Introduce themselves personally
    • Exchange contact information
    • Establish ongoing professional connections

7pm-8:30pm - Dinner Meeting

Attendees

  • Sunghee Yun
  • 홍용택 교수
  • 김영민 교수 (Associate Professor, Electrical and Computer Engineering, Seoul National University)

Discussion & Outcomes

  • Explored collaboration opportunities for Erudio Bio and K-PAI
  • Gained valuable academic insights from SNU professors

9:15pm-11:30pm - Night - Semiconductor Industry Deep Dive

Attendee

  • Sunghee Yun
  • 채관엽 상무 (Master, S.LSI Digital IP Development Team, Samsung Electronics)

Outcomes

Gained comprehensive insights into semiconductor business landscape

  • High Bandwidth Memory (HBM) business dynamics
  • Samsung and worldwide foundry business
  • Current and future AI landscape implications for semiconductor industry

19-Sep-2025 - Media Relations & Medical Equipment Regulatory Strategy

2:30pm-4:00pm - Media Interview - STRATEGIC INVESTMENT

Attendee

  • Sunghee Yun
  • 김소연 기자 (Deputy Manager, Information Media Science, Money Today)

Discussion

  • Comprehensive AI landscape overview
  • Differentiated insights unique to Sunghee’s Silicon Valley perspective
  • Agreement to meet again in Silicon Valley

CRITICAL OUTCOMES

4:30pm-5:30pm - Afternoon Coffee Chat - Gauss Labs Alumni Network

Attendee

  • Sunghee Yun
  • 이병찬 (Former Senior Applied Scientist at Gauss Labs; currently Postdoc under 신진우 교수, KAIST)

Purpose

General networking, maintain Gauss Labs alumni connections

7pm-9pm - Evening - Medical Equipment Distribution & Regulatory Insights

Attendees

  • Sunghee Yun
  • Jin Young Heo (CLO, Erudio Bio Korea)
  • 이홍국 (CEO, Asia Medical - 아시아메디칼)
  • 김정국 (Director, Regional Media Support / Newspaper Distribution Team, Korea Press Foundation)

Arranged by 성태웅 (Sunghee’s middle school friend)

CRITICAL OUTCOMES & INSIGHTS

  • Product categorization identified - Erudio’s VSA platform is categorized as biochip medical equipment
  • Regulatory pathway clarity - Must investigate MFDS (KFDA) approval procedures specifically for biochip medical equipment
  • Documentation requirements - Need to understand MFDS product definition and categories for proper regulatory pathway
  • Industry veteran perspective - 20 years distribution experience provided invaluable market insights

Assessment

Extremely fruitful, instructive, helpful, and informative meeting

9pm-11:30pm - Night - Networking with POSTECH Professor

Attendee

  • Sunghee Yun
  • 윤건수 교수 (Professor, Physics Department, POSTECH)

Outcomes

  • Gained comprehensive insights into physics
  • Established potential collaboration relations with POSTECH

20-Sep-2025 - Angel Investment Finalization & IRB Strategy

9am-10:30am - Angel Investment Breakfast - MAJOR WIN

Attendee

  • Jinsul Joo (Angel investor)

CRITICAL OUTCOME

  • Meeting initiated relationship
  • Multiple follow-up meetings conducted
  • Eventually led to ₩500M (500 million won) angel investment in Erudio Bio Korea, Inc.

10:30am - Phone Call - IRB Process Strategy

Attendee

  • Sunghee Yun
  • 송재진 교 교수 (Associate Professor, Clinical Medicine, Seoul National University Bundang Hospital)

CRITICAL STRATEGIC INSIGHT

  • IRB approval is iterative process
  • Key recommendation - Don’t aim for perfection on first submission
  • Action - Submit first draft to SNUBH to initiate conversation and process flow

12pm-1pm - Lunch - Recruitment Networking

Attendee

  • Sunghee Yun
  • 윤성호 (Recruiter)

Purpose

Potential recruitment support and general networking

6pm-8pm - Evening - Industry Networking Dinner

Attendees

  • 이경환 (CEO, KHAN; former Samsung employee)
  • 박준영 (CEO, 한반도; Yonsei Engineering, Economics MA, Cultural Anthropology PhD; Samsung Electronics Technology Advisory Professor for Semiconductor)
  • 최욱 (Team Leader PM&SE, BOS Semiconductors)
  • 엄효섭 (Team Leader, Innovation Talent Development Center, Incheon National University; bio/medical business involvement)

Outcome

  • Received medical equipment booklet from 엄효섭
  • Delivered booklet to Jin Young Heo same evening for review

9pm-10:45pm - Night - Customer Story Development

Location

Jin Young Heo’s house

Attendees

  • Sunghee Yun
  • Jin Young Heo (CLO, Erudio Bio Korea)
  • 황혜련 (Jin Young’s wife)

Purpose

Develop customer story narratives for business development materials

21-Sep-2025 - Press Strategy & Korean Medicine Collaboration

12pm-1:30pm - Lunch - Press Strategy Planning

Attendees

  • 조시영 (Team Leader, Securities Capital Markets IB Team, Asia Economy)
  • Sunghee Yun
  • Jin Young Heo (CLO, Erudio Bio Korea)

CRITICAL DECISION & STRATEGY

  • Press strategy - Expose Erudio Bio to media as frequently as possible
  • Action decided - Prepare press materials and deliver to 조시영

OUTCOMES

The meeting eventually led to this press exposure

3pm-4pm - Afternoon - AI/Cryptography Collaboration

Attendee

  • Sunghee Yun
  • 김설기 (AI · Privacy · Data Consultant)

Purpose

Explore potential AI/cryptography collaboration and general networking

6pm-7:30pm - Evening - Korean Medicine Collaboration

Attendees

  • Sunghee Yun
  • 정유용 (Senior Vice President, Korean Medical Association - 대한한의사협회)
  • 홍승훈 (Senior Engineer, SK Hynix)

Discussion

  • Potential collaboration opportunities in 한의학 (Korean traditional medicine)
  • Strategic note: 한의학 is unique medical science class existing only in South Korea
  • Represents untapped market opportunity

22-Sep-2025 - 24-Sep-2025: G-Quantum Bio Forum - LANDMARK EVENT

Location - Suwon Convention Center Duration - 3-day forum

22-Sep-2025 (Day 1) - Forum Opening & Networking

Daytime

Attended cutting-edge bio/medical technology & research presentations

6pm-9pm - Evening - Networking Dinner

Attendees

  • Multiple public servants (forum organizers, planners, executors)
  • CEOs and CTOs from bio/medical fields

Outcomes

  • Established connections with forum organizers
  • Networked with bio/medical industry leaders
  • Made acquaintance with 김성진 과장 (Manager, Suwon City Government)

Post-Dinner Activity

  • Suwon castle and city night tour
  • Experienced beautiful nighttime landscape of historic Suwon

23-Sep-2025 (Day 2) - BREAKTHROUGH DAY

10am-12pm - Morning - K-BioX Mentoring Event

CRITICAL MEETING - Andrew Radin (AI Head, StartX) - MAJOR STRATEGIC WIN

Meeting Type - In-person, face-to-face, personal meeting

CRITICAL OUTCOMES

  • StartX Program Endorsement
    • Andrew Radin personally advised Sunghee to apply for StartX program
    • Andrew’s endorsement essentially guarantees acceptance
    • Major Silicon Valley accelerator validation
  • Successful Pitch Execution
    • Emphasized Erudio Bio’s technical excellence
    • Highlighted entrepreneurial strength
    • Showcased strategic positioning
    • Presented business model
    • Featured Gates Foundation Award prominently
    • Self-assessment - “I did quite well on that pitch!”
  • Strategic Impact
    • Connection to one of Silicon Valley’s most influential AI leaders
    • Path to premier accelerator program
    • Validation from top-tier Silicon Valley ecosystem

Silicon Valley Network Expansion

*Introduced by Sunghee to Jin Young Heo:

  • 이시연 박사 (K-BioX Representative Operating Committee Member, Stanford Medical School)
  • 임성원 대표 (CEO, ImpriMed)
  • 박군호 대표 (CEO, PathoBrainSeq)

Outcome

Expanded Jin Young’s Silicon Valley network with key biotech contacts

12pm-1pm - Special Lunch (Invitee-Only)

  • Sunghee secured Jin Young Heo’s attendance through special request
  • Executive-level networking opportunity

3pm-6pm - Afternoon - G-BIVA Innovation Salon (Exclusive Invitees-Only Event)

  • Sunghee secured Jin Young Heo’s attendance through special permission
  • Presented Erudio Bio, Inc. to exclusive audience
  • Learned from other CEOs’ presentations
  • High-level strategic discussions

7pm-9pm - Evening - Conference Main Dinner

  • Extensive networking with students and K-BioX members
  • Post-dinner - Special Suwon village tour

24-Sep-2025 - Regulatory & Legal Deep Dive

All-Day Event

Regulatory Science Conference and Legal Strategy Seminar

Attendees

  • Sunghee Yun (virtual)
  • Jin Young Heo (virtual)

Program

PDF

10pm-12:10pm - Morning Session - 규제과학 컨퍼런스

  • Bioequivalence and regulatory guidelines
  • Research development for regulatory approval
  • AI application in drug development processes

1:30pm-4:30pm - Afternoon Session - 법률 전략 세미나

  • IPO and legal strategies for biotech companies
  • IP licensing and legal frameworks
  • Data/privacy legal considerations
  • Investment structures and exit strategies

CRITICAL OUTCOMES

Comprehensive understanding of

  • MFDS/KFDA regulatory pathways for medical devices
  • Legal frameworks for biotech companies in Korea
  • IP strategy for medical device commercialization
  • Investment and exit planning considerations
  • All relevant regulatory requirements for Erudio Bio’s product category

7pm-8:30pm - Evening - Recruitment Strategy

Attendee

  • Sunghee Yun
  • 조연희 (TL/Talent Acquisition Specialist, SK Hynix; former Gauss Labs recruiter)

Purpose

Explore potential collaboration for Erudio Bio Korea recruitment needs

25-Sep-2025 - Venture Capital Breakthrough & Strategic Partnerships

2pm-3:50pm - Path Way Investment VC Meeting - LANDMARK OUTCOME

Location

425 Eonju-ro, Gangnam District, Seoul

Attendees

  • Erudio Bio
    • Sunghee Yun
  • Path Way Investment
    • 이상진 대표 (CEO, Path Way Partners)
    • 문초혜 전무이사 (Executive Director / Ph.D. Engineering / Adjunct Professor, Molecular Medicine & Biopharmaceuticals, Seoul National University, Path Way Investment)
    • 박윤호 투자기획실 대리 (Deputy Director, Investment Planning / Research Analyst, Path Way Partners)

Introduced and Arranged by 편재호 교수 (San Jose State University)

Scheduled Duration

60 minutes

Actual Duration

110 minutes (engagement so strong no one noticed time)

CRITICAL OUTCOMES

  • Technology Deep Dive & Business Model Expansion
    • 문초혜 전무이사 asked highly sophisticated technology questions
    • AUDACIOUS BUSINESS MODEL PROPOSED
      • Beyond lead optimization stage (current assumption)
      • VSA could contribute to preclinical stage
      • VSA could even contribute to clinical stage
    • Strategic impact - Significantly expands Erudio Bio’s total addressable market
  • Series A Commitment
    • Several days post-meeting - Received text from 이상진 CEO
    • Path Way confirmed interest in participating in Erudio Bio Series A fundraising round
  • Strategic Validation - MAJOR WINS
    • Confirmed market responds very favorably to Erudio Bio
    • Validated tech/market strategy is sound and compelling
    • Added high-caliber Korean VC to investor network
    • Expanded understanding of VSA platform’s market potential

Assessment

Meeting exceeded all expectations - technology validation, business model expansion, and investor commitment achieved

6pm-8pm - Evening - Pion Corporation Partnership Exploration

Dinner Attendees

  • Sunghee Yun
  • Jin Young Heo (CLO, Erudio Bio Korea)
  • 전찬석 대표 (CEO, VCAT.AI, Pion Corporation)

Purpose

  • General networking
  • Explore potential technical partnership with Pion Corporation

9pm-11pm - Night - Semiconductor Industry Insights (Part 2)

Location

채관엽’s house

Attendees

  • Sunghee Yun
  • Jin Young Heo
  • 채관엽 (Master, S.LSI Digital IP Development Team, Samsung Electronics)

Purpose

  • General networking
  • Continued semiconductor industry insights and networking (follow-up to Sep 18 meeting)

26-Sep-2025 - Angel Investment Finalization & Korean Medicine AI Initiative

12pm-1pm - Lunch - D.Notitia Partnership Discussion

Attendees

  • Sunghee Yun
  • Jin Young Heo
  • 정무경 (CEO, D.notitia)
  • 손준혁 (COO / VP / Co-Founder, D.notitia)

Purpose

General networking and explore potential partnership opportunities

Evening: Angel Investment Terms Finalization

Attendee

  • Sunghee Yun
  • Angel Investor (Sunghee’s High School Senior - USD 140k commitment)

CRITICAL OUTCOME

  • Discussed and finalized investment terms
  • Obtained investor’s specific requests
  • Immediately communicated details to Kee-hyun Paik for execution

7:30pm-12am - Night - [Association of Korean Medicine] 2nd Korean Medicine-AI Integration Task Force Meeting - MAJOR ENGAGEMENT

Event

[Association of Korean Medicine (대한한의사협회)] 2nd Korean Medicine-AI Integration Task Force Meeting

Role

AI Task Force Advisory Committee Member

Activity

  • Delivered AI talk to Korean Medicine Association AI Task Force
    • “From Silicon Valley to Biotech Valley - How Agentic AI is Reshaping Drug Discovery” abstract
  • Response Amazing engagement from all committee members

Attendees Met

  • Multiple 한의사 (Korean medicine doctors)
  • 한방병원 원장님들 (Korean medicine hospital directors)
  • AI Task Force members

Post-Meeting Networking

  • Participated in chicken & beer networking session
  • Further relationship building with Korean medicine community

Outcome

Deepened engagement with Korean medicine AI integration initiative - unique market opportunity

27-Sep-2025 - Humanities & Social Sciences Networking, Return to US

2pm-4pm - Afternoon - Humanities & Social Sciences Gathering

Invited by James Rhee (Johnson Chair of Entrepreneurship; Owner, CEO, and Author @ red helicopter)

Attendees

  • Professors and academics
  • Humanities and social sciences experts

Discussion

Humanities and social sciences issues and perspectives

Purpose

General networking, interdisciplinary perspective building

Evening: Return to Silicon Valley

Flight: OZ 212, ICN → SFO (departed 8:55pm KST, arrived 3:30pm PDT same day)

FUNDRAISING

Angel Investment Secured - USD 140k

Investor Sunghee’s High School Senior

Timeline

  • 20-Sep-2025 - Initial breakfast meeting
  • 26-Sep-2025 - Terms finalized
  • Amount - USD 140,000

Status Terms finalized, pending execution

Angel Investment Under Negotiation - ₩500M

Investor Jinsul Joo

Timeline

  • 20-Sep-2025 - Initial breakfast meeting initiated relationship
  • Multiple follow-up meetings conducted
  • Amount - ₩500,000,000 (500 million won)

Status - Considering Investment for Erudio Bio Korea, Inc.

Series A Commitment - Path Way Investment

Investor - Path Way Partners/Investment

Key Contact - 이상진 대표 / 문초혜 전무이사

Timeline

  • 25-Sep-2025 - Initial meeting (110-minute deep dive)
  • Post-meeting - Text confirmation of Series A interest

Status - Commitment obtained, timing TBD

PARTNERSHIP

StartX Program - Silicon Valley Accelerator

Contact - Andrew Radin (AI Head, StartX)

Outcome - Personal endorsement and application recommendation (essentially guarantees acceptance)

Status - Pending application submission

Korean Medicine AI Integration

Organization - Korean Medical Association

Role - AI Task Force Advisory Committee Member

Status - Active ongoing engagement

Pion Corporation Technical Partnership

Contact - 전찬석 대표 (CEO, VCAT.AI, Pion Corporation)

Status - Initial discussion, exploring opportunities

D.Notitia Partnership

Contacts - 정무경 (CEO), 손준혁 (COO/VP/Co-Founder)

Status - Having maintained good relationship for a long time, exploring opportunities

NETWORKING

POSTECH Faculty Network

Contact - 한수희 교수 (Associate Professor, Director of Unmanned Vehicle Research Institute, POSTECH)

Focus - Robotics, edge computing, AI technology collaboration potential

Korea University Business School (KUBS)

Contact - 김기훈 교수 (Professor, Graduate School of Business)

Focus - K-PAI and Erudio Bio collaboration opportunities

Seoul National University (SNU) EE Department

Contacts

  • 홍용택 교수 (Department Chair, Electrical and Computer Engineering)
  • 김영민 교수 (Associate Professor, Electrical and Computer Engineering)

Outcome - Extremely successful seminar with exceptional audience engagement, extensive post-seminar networking

Silicon Valley-Korea Bridge

G-Quantum Bio Forum Connections:

  • 이시연 박사 (K-BioX Representative, Stanford Medical School)
  • 임성원 대표 (CEO, ImpriMed)
  • 박군호 대표 (CEO, PathoBrainSeq)

Media Relations

Contact - 김소연 (Deputy Manager, Money Today)

Outcome - Two published articles including Gates Foundation feature

Korean SME Association

Contact - 이상엽 (Vice Chairman, Korea Strong Small and Medium Enterprises Association)

Potential - Business development network throughout Korean SME ecosystem

Recruitment Network

Contacts

  • 윤성희 (Recruiter)
  • 조연희 (TL/Talent Acquisition Specialist, SK Hynix; former Gauss Labs)

Humanities & Social Sciences

Contact - James Rhee (Johnson Chair of Entrepreneurship @ red helicopter)

Network - Professors and experts in humanities and social sciences